<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:og="http://ogp.me/ns#" xmlns:fb="http://www.facebook.com/2008/fbml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <script type="text/javascript">function setMobileCookie(name,value,exdays){var exdate=new Date();exdate.setDate(exdate.getDate()+exdays);var expire=((exdays==null)?"":"; expires="+exdate.toUTCString()),path='; path=/';document.cookie=name+"="+escape(value)+expire+path}
function getMobileCookie(name){var c_value=document.cookie,c_start=c_value.indexOf(" "+name+"=");if(c_start==-1)c_start=c_value.indexOf(name+"=");if(c_start==-1){c_value=null}else{c_start=c_value.indexOf("=",c_start)+1;var c_end=c_value.indexOf(";",c_start);if(c_end==-1)c_end=c_value.length;c_value=unescape(c_value.substring(c_start,c_end))};return c_value}
function getMobileParameter(paramName){var searchString=window.location.search.substring(1),i,val,params=searchString.split("&");for(i=0;i<params.length;i++){val=params[i].split("=");if(val[0]==paramName)return unescape(val[1])};return null}
function get_utm_query_values(){var i,vars={},param,referrerSet=false,params=window.location.search.substring(1).split('&');for(i=0;i<params.length;i++){param=params[i].split('=');if(param[0].match(/^utm_/)){vars[param[0]]=param[1];if(param[0]=='utm_referrer')referrerSet=true}};if(document.referrer&&!referrerSet)vars.utm_referrer=encodeURIComponent(document.referrer);return vars}
function update_query_string_parameter(uri,key,value){var re=new RegExp("([?|&])"+key+"=.*?(&|#|$)","i");if(uri.match(re)){return uri.replace(re,'$1'+key+"="+value+'$2')}else{var hash='',separator=uri.indexOf('?')!==-1?"&":"?";if(uri.indexOf('#')!==-1){hash=uri.replace(/.*#/,'#');uri=uri.replace(/#.*/,'')};return uri+separator+key+"="+value+hash}}
function update_utm_params_from_current_url(uri){var utm_params=get_utm_query_values();for(var key in utm_params)uri=update_query_string_parameter(uri,key,utm_params[key]);return uri};var viewDesktop=getMobileParameter('viewDesktop'),enableDesktop=getMobileParameter('enableDesktop'),benzingaMobile=getMobileCookie('benzingaMobile'),benzingaMobileUA=getMobileCookie('benzingaMobileUA');if(benzingaMobileUA!=navigator.userAgent)setMobileCookie('benzingaMobileUA',navigator.userAgent,1);if(enableDesktop==1){setMobileCookie('benzingaMobile',0,1);benzingaMobile=0};if(benzingaMobile===0||benzingaMobile==='0'||viewDesktop==1);else if(benzingaMobile==1||navigator.userAgent.match(/(iPad)|(iPhone)|(iPod)|(opera mini)|(blackberry)|(android)|(palm os)|(palm)|(hiptop)|(avantgo)|(plucker)|(xiino)|(blazer)|(elaine)|(iris)|(3g_t)|(windows ce)|(opera mobi)|(windows ce; smartphone;)|(windows ce; iemobile)|(windows phone)|(smartphone)|(kindle)|(psp)/i)){if(!benzingaMobile)setMobileCookie('benzingaMobile',1,2);document.location.href=update_utm_params_from_current_url('http://m.benzinga.com/article/8791297')}</script>
  <!--[if IE]>
  <script type="text/javascript">document.createElement("header");document.createElement("footer");</script>
  <script type="text/javascript" src="/sites/all/themes/bz2/js/excanvas.js"></script>
  <![endif]-->
  <script type="text/javascript">var ord = Math.random() * 10000000000000000</script>  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<script type="text/javascript" src="https://widgets.tipranks.com/content/embed.js?2" async></script>
<script type="text/javascript" src="http://a.postrelease.com/serve/load.js?async=true"></script>
<link type="text/css" rel="stylesheet" media="all" href="//maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css" />
<script>
  (function(w,d,s,o){
    w[o.callback] = function(){var a = d.getElementById('_cahiddenstyle'); if (a)a.parentNode.removeChild(a);}
    setTimeout(function(){w[o.callback]()}, o.timeout);
    var hs = d.createElement('style'),hc = "body{visibility:hidden !important;opacity:0 !important;filter:alpha(opacity=0) !important;background:none !important;}", h = d.getElementsByTagName('script')[0],
    f = 'https://changeagain.me/sites/57614363.js?screen_width=' + s.width + '&screen_height=' + s.height + '&page=' + encodeURIComponent(d.URL), r = d.createElement('script');
    hs.setAttribute('id', '_cahiddenstyle'); hs.setAttribute('type', 'text/css');
    if (hs.styleSheet)hs.styleSheet.cssText = hc; else hs.appendChild(d.createTextNode(hc)); h.parentNode.insertBefore(hs,h);
    r.setAttribute("type","text/javascript"); r.setAttribute("src", f); r.onerror=function(){w[o.callback]()}; h.parentNode.insertBefore(r,h);
  })(window, document, screen, {timeout: 1500, callback: '_changeagain_finish'});
</script>
<meta http-equiv="x-dns-prefetch-control" content="on" />
<link rel="dns-prefetch" href="//cdn1.benzinga.com" />
<link rel="dns-prefetch" href="//cdn2.benzinga.com" />
<link rel="dns-prefetch" href="//cdn3.benzinga.com" />
<link rel="dns-prefetch" href="//cdn4.benzinga.com" />
<script charset="utf-8" type="text/javascript" src="https://js.hsforms.net/forms/v2.js"></script>
<link rel="shortcut icon" href="https://cdn1.benzinga.com/files/bz2_favicon_2.ico" type="image/x-icon" />
<meta name="description" content="BMO Capital Markets said Biogen Inc (NASDAQ: BIIB) shares should trade higher, despite a recent drug trial miss, on CTAD data (Clinical Trials on ..." />
<meta name="language" content="English" />
<meta name="copyright" content="Copyright 2014 Benzinga. All rights reserved." />
<meta name="fo-verify" content="101a0095-334d-4935-b87e-0e8fc771214e" />
<link rel="canonical" href="https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8791297/despite-drug-trial-miss-heres-why-biogen-should-trade-hi" />
<meta property="Benzinga for iOS" content="app-id=688949481, app-argument=https://itunes.apple.com/us/app/id688949481">
<meta name="twitter:card" content="summary_large_image" />
<meta name="twitter:site" content="@benzinga" />
<meta property="og:site_name" content="Benzinga" />
<meta property="og:url" content="https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8791297/despite-drug-trial-miss-heres-why-biogen-should-trade-hi" />
<meta property="og:title" content="Biogen Stock: Despite Drug Trial Miss, BIIB Should Trade Higher" />
<meta name="twitter:title" content="Biogen Stock: Despite Drug Trial Miss, BIIB Should Trade Higher" />
<meta property="og:type" content="article" />
<meta property="og:description" content="BMO Capital Markets said Biogen Inc (NASDAQ: BIIB) shares should trade higher, despite a recent drug trial miss, on CTAD data (Clinical Trials on Alzheimer&#39;s Disease).
The..." />
<meta name="twitter:description" content="BMO Capital Markets said Biogen Inc (NASDAQ: BIIB) shares should trade higher, despite a recent drug trial miss, on CTAD data (Clinical Trials on Alzheimer&#39;s Disease).
The..." />
<meta name="twitter:image:src" content="https://cdn3.benzinga.com/files/imagecache/600x400xUP/images/story/2012/hands-981400_1920_1.jpg" />
<meta property="og:image" content="https://cdn3.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/images/story/2012/hands-981400_1920_1.jpg" />
<link rel="image_src" href="https://cdn3.benzinga.com/files/imagecache/bz2_opengraph_meta_image_400x300/images/story/2012/hands-981400_1920_1.jpg" />
<link rel="author" href="https://plus.google.com/110971701518125066702" />
<link rel="shorturl" id="shorturl" type="text/html" href="https://benzinga.com/z/8791297" />
<link rel="apple-touch-icon" href="https://cdn1.benzinga.com/sites/all/modules/custom/bz2_site/images/ios/benzinga-ios.png" />
<link rel="schema.DC" href="http://purl.org/dc/elements/1.1/" />
<link rel="schema.DCTERMS" href="http://purl.org/dc/terms/" />
<meta name="DC.Date" scheme="ISO8601" content="2016-12-09" />
<meta name="DC.Creator" content="Manikandan Raman" />
<meta name="DC.Subject" xml:lang="EN" content="Biogen Stock: Despite Drug Trial Miss, BIIB Should Trade Higher" />
<meta name="DC.Publisher" content="Benzinga" />
<meta name="DC.Rights" content="Copyright 2017 Benzinga. All rights reserved." />
<meta property="fb:admins" content="648186192" />
<meta name="syndication-source" content="https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8791297/despite-drug-trial-miss-heres-why-biogen-should-trade-hi">
  <title>Biogen Stock: Despite Drug Trial Miss, BIIB Should Trade Higher | Benzinga</title>
  <link href='//fonts.googleapis.com/css?family=Open+Sans:400,700italic,400italic,700|Open+Sans+Condensed:700,300' rel='stylesheet' type='text/css'>
  <link type="text/css" rel="stylesheet" media="all" href="https://cdn3.benzinga.com/files/advagg_css/css_765bbc47722ec5d04345e311e701a77a_454.css" />
<link type="text/css" rel="stylesheet" media="all" href="https://cdn2.benzinga.com/files/advagg_css/css_a729b15953e3cef94dc3c52b691cc107_16.css" />
  <!--[if lte IE 8]>
	  <link rel="stylesheet" type="text/css" href="/sites/all/themes/bz2/css/ie.css" />
  <![endif]-->
  <script type="text/javascript" src="https://cdn3.benzinga.com/files/advagg_js/js_6963a2e9b83929c861c6104fcb7786cd_279.js"></script>
<script type="text/javascript" src="https://cdn1.benzinga.com/files/advagg_js/js_9291b3ab6418803409db92ad9a7406c2_282.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"basePath":"\/","bzads":{"enable_ads":1},"bz2_site":{"base_url":"https:\/\/www.benzinga.com","base_url_protless":"\/\/www.benzinga.com","base_path":"\/","current_nid":"8791297","is_front":false,"is_bz_post":"1","is_bzpro_post":"1"},"bzApp":{"basePath":"\/sites\/all\/modules\/custom\/bz_watchlist\/","dataAPI":"\/\/data.benzinga.com\/"},"nodejs":{"nodejs_server":"https:\/\/bznode.benzinga.com\/","sockio_server":"https:\/\/bznodews.benzinga.com\/"},"bz_js":{"analytics_properties":{"authorId":"97707","authorName":"Manikandan Raman","channels":"Analyst Color:Biotech:News:Health Care:Price Target:Reiteration:Analyst Ratings:Movers:General","contentType":"story"},"nodeCreated":"1481307496"},"drupal":{"arg":["node","8791297"]},"bz_partner_widget":{"baseUrl":"https:\/\/www.benzinga.com"},"bz_social":{"fbChannelURL":"https:\/\/www.benzinga.com\/sites\/all\/modules\/custom\/bz_social\/misc\/fb-channel.html"},"bzcustom":{"bzcustom_dest":"node\/8791297","ga_authorname":"97707:Manikandan Raman","autorefresh_node_page":true,"signup_popup":true},"disqus":{"url":"http:\/\/www.benzinga.com\/analyst-ratings\/analyst-color\/16\/12\/8791297\/despite-drug-trial-miss-heres-why-biogen-should-trade-hi","title":"Despite Drug Trial Miss, Here\u0026#039;s Why Biogen Should Trade Higher","identifier":"node\/8791297","shortname":"bzdisqus"},"CToolsUrlIsAjaxTrusted":{"\/user":[true,true],"\/search\/fast":true}});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
!function(){var analytics=window.analytics=window.analytics||[];if(!analytics.initialize)if(analytics.invoked){window.console&&console.error&&console.error("Segment snippet included twice.")}else{analytics.invoked=!0;analytics.methods=["trackSubmit","trackClick","trackLink","trackForm","pageview","identify","reset","group","track","ready","alias","debug","page","once","off","on"];analytics.factory=function(t){return function(){var e=Array.prototype.slice.call(arguments);e.unshift(t);analytics.push(e);return analytics}};for(var t=0;t<analytics.methods.length;t++){var e=analytics.methods[t];analytics[e]=analytics.factory(e)};analytics.load=function(t){var e=document.createElement("script");e.type="text/javascript";e.async=!0;e.src=("https:"===document.location.protocol?"https://":"http://")+"cdn.segment.com/analytics.js/v1/"+t+"/analytics.min.js";var n=document.getElementsByTagName("script")[0];n.parentNode.insertBefore(e,n)};analytics.SNIPPET_VERSION="4.0.0";analytics.load("wtomjaowem")}}();
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var googletag=googletag||{};googletag.cmd=googletag.cmd||[];(function(){var gads=document.createElement('script');gads.async=true;gads.type='text/javascript';var useSSL='https:'==document.location.protocol;gads.src=(useSSL?'https:':'http:')+'//www.googletagservices.com/tag/js/gpt.js';var node=document.getElementsByTagName('script')[0];node.parentNode.insertBefore(gads,node)})();
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
googletag.cmd.push(function(){googletag.defineSlot('/4107070/Benzinga:300x250',[300,250],'div-gpt-ad-1346271905130-0').addService(googletag.pubads());googletag.defineSlot('/4107070/Benzinga:728x90-TopBanner',[728,90],'div-gpt-ad-1353985507499-0').addService(googletag.pubads());googletag.pubads().setTargeting("BZ_NID","8791297");googletag.pubads().setTargeting("BZ_PTYPE","story");googletag.pubads().setTargeting("BZ_AUTHOR","Manikandan Raman");googletag.pubads().setTargeting("BZ_CHANNEL",["Analyst Color","Biotech","News","Health Care","Price Target","Reiteration","Analyst Ratings","Movers","General"]);googletag.enableServices()});
//--><!]]>
</script>
    <script type="text/javascript"> </script>
</head>
<body 
  class="not-front not-logged-in page-node node-type-story no-sidebars"
  data-ng-app="bzApp">
      <div id="bz3-header">	
	<div id="bz3-header-top-wrapper">
		<div id="bz3-header-top">
		  <div id="bz3-header-top-links">
		    <ul>
		      <li class="active benzinga">
		        <a href="/" class="active">Benzinga</a>
		      </li>
		      <li class="benzingapro">
		        <a href="http://pro.benzinga.com" target="_blank">Benzinga Pro</a>
		      </li>
		      <li class="marketfy">
		        <a href="http://marketfy.com" target="_blank">Marketfy</a>
		      </li>
          <li class="bz-cloud-link">
            <a href="http://cloud.benzinga.com" target="_blank" title="Benzinga Cloud Financial Data and API Services">Financial Data &amp; APIs</a>
          </li>
          <li class="bz-awards">
            <a href="http://benzingafintechawards.com" target="_blank" title="Fintech Awards">Fintech Awards</a>
          </li>
          <li class="premarket-prep">
            <a href="http://premarket.benzinga.com" target="_blank" title="Premarket Prep">Premarket Prep</a>
          </li>
		    </ul>
		  </div>
	  	<div id="bz3-header-top-content">
                  <div class="panel-pane pane-block pane-bz-user-bz-user-login-header" >
  
  
  
  <div class="pane-content">
    <div id="registration-modal" class="reveal-modal modal"><form action="/user"  accept-charset="UTF-8" method="post" id="bz-user-registration-form">
<div><div class="modal-header"><h2>Membership is Free</h2><h3>What are you waiting for? Sign up now!</h3></div><div class="validation-wrapper"><div class="form-item" id="edit-username-wrapper">
 <label for="edit-username">Username: </label>
 <input type="text" maxlength="128" name="username" id="edit-username" size="60" value="" class="form-text username" placeholder="John Smith" />
</div>
<div class="form-username-loading"></div><div class="form-username-available">Username available!</div><div class="form-username-unavailable">Username taken!</div></div><div class="validation-wrapper"><div class="form-item" id="edit-email-wrapper">
 <label for="edit-email">Email: </label>
 <input type="text" maxlength="128" name="email" id="edit-email" size="60" value="" class="form-text email" placeholder="example@mail.com" />
</div>
<div class="form-email-loading"></div><div class="form-email-available">Email available!</div><div class="form-email-unavailable">Email taken!</div></div><div class="form-item" id="edit-password-wrapper">
 <label for="edit-password">Password: </label>
 <input type="password" name="password" id="edit-password"  maxlength="128"  size="60"  class="form-text password" placeholder="5 characters or more" />
</div>
<div class="form-item" id="edit-more-wrapper">
 <label for="edit-more">Leave blank: </label>
 <input type="text" maxlength="128" name="more" id="edit-more" size="60" value="" class="form-text hidden more" />
</div>
<input type="hidden" name="ready" id="edit-ready" value="0"  class="ready" />
<input type="submit" name="op" id="edit-submit" value="Register"  class="form-submit nice green button submit userbtn" />
<span class="another-choice">OR</span><input type="button" class="text-only nice blue button login-instead userbtn" value="Already Have an Account" /><input type="hidden" name="form_build_id" id="form-f33gDn1R3lzsIAvK2NTbmioblhlzuYpH-n3KeK7U9EY" value="form-f33gDn1R3lzsIAvK2NTbmioblhlzuYpH-n3KeK7U9EY"  />
<input type="hidden" name="form_id" id="edit-bz-user-registration-form" value="bz_user_registration_form"  />

</div></form>
</div><div id="login-modal" class="reveal-modal modal"><form action="/user"  accept-charset="UTF-8" method="post" id="bz-user-login-form">
<div><div class="modal-header">
  <h2>Free Account Login</h2>
  <span class="tagline"><a href="http://pro.benzinga.com">Click here to access your premium account</a></span>
</div><div class="form-item" id="edit-username-1-wrapper">
 <label for="edit-username-1">Username or email: </label>
 <input type="text" maxlength="128" name="username" id="edit-username-1" size="60" value="" class="form-text username" placeholder="example@mail.com" />
</div>
<div class="form-item" id="edit-password-1-wrapper">
 <label for="edit-password-1">Password: </label>
 <input type="password" name="password" id="edit-password-1"  maxlength="128"  size="60"  class="form-text password" placeholder="5 characters or more" />
</div>
<input type="hidden" name="ready" id="edit-ready-1" value="0"  class="ready" />
<input type="submit" name="op" id="edit-submit-1" value="Login"  class="form-submit nice green button submit userbtn" />
<span class="another-choice">OR</span>
<input type="button" class="text-only nice blue button register-instead userbtn" value="Create an Account?" >
<a href="/user/password" class="text-only" style="float: right; margin-top: 5px;">Forgot password?</a>'
<div class="login-pro-button">
  <span>Looking for</span>
  <a href="http://pro.benzinga.com">
    <img src="/sites/all/themes/bz2/images/bz-pro-logo-no-glow-1.png" alt="Benzinga Pro">
  </a>
  <span>?</span>
  <a href="http://pro.benzinga.com">
    <button href="#" class="nice button submit userbtn">CLICK HERE</button>
  </a>
</div><input type="hidden" name="form_build_id" id="form-0xvW-SDFE65bXH9cd5ilDYmb4coUQEL4vzez5jugvJw" value="form-0xvW-SDFE65bXH9cd5ilDYmb4coUQEL4vzez5jugvJw"  />
<input type="hidden" name="form_id" id="edit-bz-user-login-form" value="bz_user_login_form"  />

</div></form>
</div><div id="login-header-items">  <ul>    <li class="second"><a href="/contribute">Contribute</a></li>    <li><a href="/user" id="user-login">Login</a></li>    <li><a href="/user" id="user-register">Sign up</a></li>  </ul></div>  </div>

  
  </div>
              </div> <!-- /bz3-header-top-content -->
    </div> <!-- /bz3-header-top -->
  </div> <!-- /bz3-header-top-wrapper -->
  <div id="bz3-header-logos-wrapper">
    <div id="bz3-header-logos">
      <div id="bz-logo"><a href="/">Benzinga - Feed Your Mind.</a></div>
      <div id="banner-ad">
        <div class="ads-block">
          <div style='width: 728px; height: 90px; overflow: hidden;'><div id='ic_728x90'><script src='//ads.investingchannel.com/adtags/benzinga/equities/728x90.js?ad_element_id=ic_728x90 type='text/javascript'
          charset='utf-8' async></script></div></div>
        </div>
      </div>
    </div>
  </div>
  <div id="bz3-header-menu-wrapper">
    <div id="bz3-header-menu">
		          <div class="panel-pane pane-block pane-menu-block-3" >
  
  
  
  <div class="pane-content">
    <div class="menu-block-3 menu-name-menu-v3-main parent-mlid-0 menu-level-1">
  <ul class="menu"><li class="expanded first menu-mlid-878826 home"><a href="/" title="" class="bz3-menu-homepage-link"><span>Home</span></a><ul class="menu"><li class="leaf first menu-mlid-890912 bestofbenzinga"><a href="/best-of-benzinga" title=""><span>Best of Benzinga</span></a></li>
<li class="leaf menu-mlid-878857 careers"><a href="http://jobs.benzinga.com/" title=""><span>Careers</span></a></li>
<li class="leaf menu-mlid-878854 about"><a href="/about" title=""><span>About</span></a></li>
<li class="leaf menu-mlid-878856 contactus"><a href="/contact" title=""><span>Contact Us</span></a></li>
<li class="leaf menu-mlid-920307 partners"><a href="http://www.benzinga.com/bzwire" title=""><span>Partners</span></a></li>
<li class="leaf last menu-mlid-1111033 benzingafintechawards"><a href="http://benzingafintechawards.com/" title=""><span>Benzinga Fintech Awards</span></a></li>
</ul></li>
<li class="expanded menu-mlid-878822 news"><a href="/news" title="All corporate News"><span>News</span></a><ul class="menu"><li class="leaf first menu-mlid-878845 earnings"><a href="/news/earnings" title=""><span>Earnings</span></a></li>
<li class="leaf menu-mlid-878846 guidance"><a href="/news/guidance" title=""><span>Guidance</span></a></li>
<li class="leaf menu-mlid-878848 dividends"><a href="/news/dividends" title=""><span>Dividends</span></a></li>
<li class="leaf menu-mlid-878868 ma"><a href="/news/m-a" title=""><span>M&A</span></a></li>
<li class="leaf menu-mlid-878862 buybacks"><a href="/news/buybacks" title=""><span>Buybacks</span></a></li>
<li class="leaf menu-mlid-878836 legal"><a href="/news/legal" title=""><span>Legal</span></a></li>
<li class="leaf menu-mlid-1056501 interviews"><a href="/interview" title=""><span>Interviews</span></a></li>
<li class="leaf menu-mlid-878860 management"><a href="/news/management" title=""><span>Management</span></a></li>
<li class="leaf menu-mlid-878838 retailsales"><a href="/news/retail-sales" title=""><span>Retail Sales</span></a></li>
<li class="leaf menu-mlid-878844 offerings"><a href="/news/offerings" title=""><span>Offerings</span></a></li>
<li class="leaf menu-mlid-878839 ipos"><a href="/news/ipos" title=""><span>IPOs</span></a></li>
<li class="leaf menu-mlid-878861 insidertrades"><a href="/news/insider-trades" title=""><span>Insider Trades</span></a></li>
<li class="leaf last menu-mlid-878863 biotechfda"><a href="/news/fda" title=""><span>Biotech/FDA</span></a></li>
</ul></li>
<li class="expanded menu-mlid-878820 markets"><a href="/markets" title=""><span>Markets</span></a><ul class="menu"><li class="leaf first menu-mlid-878853 premarket"><a href="/pre-market-outlook" title=""><span>Pre-Market</span></a></li>
<li class="leaf menu-mlid-878850 afterhours"><a href="/after-hours-center" title=""><span>After Hours</span></a></li>
<li class="leaf menu-mlid-878849 movers"><a href="/movers" title=""><span>Movers</span></a></li>
<li class="leaf menu-mlid-878851 forex"><a href="/markets/forex" title=""><span>Forex</span></a></li>
<li class="leaf menu-mlid-878858 commodities"><a href="/markets/commodities" title=""><span>Commodities</span></a></li>
<li class="leaf menu-mlid-878835 options"><a href="/markets/options" title=""><span>Options</span></a></li>
<li class="leaf menu-mlid-1034073 binaryoptions"><a href="/markets/binary-options" title=""><span>Binary Options</span></a></li>
<li class="leaf menu-mlid-878829 bonds"><a href="/markets/bonds" title=""><span>Bonds</span></a></li>
<li class="leaf menu-mlid-878832 futures"><a href="/markets/futures" title=""><span>Futures</span></a></li>
<li class="leaf menu-mlid-878837 globaleconomics"><a href="/economics" title=""><span>Global Economics</span></a></li>
<li class="leaf menu-mlid-878866 previews"><a href="/trading-ideas/previews" title=""><span>Previews</span></a></li>
<li class="leaf menu-mlid-878852 reviews"><a href="/reviews" title=""><span>Reviews</span></a></li>
<li class="leaf last menu-mlid-878823 smallcap"><a href="/news/small-cap" title=""><span>Small-Cap</span></a></li>
</ul></li>
<li class="expanded menu-mlid-878827 active-trail ratings"><a href="/analyst-ratings" title="" class="active-trail"><span>Ratings</span></a><ul class="menu"><li class="leaf first menu-mlid-878830 active-trail analystcolor"><a href="/analyst-ratings/analyst-color" title="" class="active-trail"><span>Analyst Color</span></a></li>
<li class="leaf menu-mlid-878833 downgrades"><a href="/analyst-ratings/downgrades" title=""><span>Downgrades</span></a></li>
<li class="leaf menu-mlid-878834 upgrades"><a href="/analyst-ratings/upgrades" title=""><span>Upgrades</span></a></li>
<li class="leaf menu-mlid-878831 initiations"><a href="/analyst-ratings/initiation" title=""><span>Initiations</span></a></li>
<li class="leaf last menu-mlid-878828 pricetarget"><a href="/analyst-ratings/price-target" title=""><span>Price Target</span></a></li>
</ul></li>
<li class="expanded menu-mlid-878825 ideas"><a href="/trading-ideas" title="Trading-Ideas"><span>Ideas</span></a><ul class="menu"><li class="leaf first menu-mlid-878859 longideas"><a href="/trading-ideas/long-ideas" title=""><span>Long Ideas</span></a></li>
<li class="leaf menu-mlid-878865 shortideas"><a href="/trading-ideas/short-ideas" title=""><span>Short Ideas</span></a></li>
<li class="leaf menu-mlid-878842 technicals"><a href="/trading-ideas/technicals" title=""><span>Technicals</span></a></li>
<li class="leaf menu-mlid-878864 fromthepress"><a href="/media" title=""><span>From The Press</span></a></li>
<li class="leaf menu-mlid-878843 jimcramer"><a href="/media/jim-cramer" title=""><span>Jim Cramer</span></a></li>
<li class="leaf menu-mlid-878841 rumors"><a href="/news/rumors" title=""><span>Rumors</span></a></li>
<li class="leaf last menu-mlid-878867 etfs"><a href="/etfs" title=""><span>ETFs</span></a></li>
</ul></li>
<li class="expanded menu-mlid-878821 tech"><a href="/tech" title=""><span>Tech</span></a><ul class="menu"><li class="leaf first last menu-mlid-878840 startups"><a href="/startups" title=""><span>Start-Ups</span></a></li>
</ul></li>
<li class="leaf menu-mlid-1120140 fintech"><a href="/topic/fintech" title=""><span>Fintech</span></a></li>
<li class="leaf menu-mlid-1060619 personalfinance"><a href="/personal-finance" title=""><span>Personal Finance</span></a></li>
<li class="leaf menu-mlid-878824 marketfy"><a href="http://marketfy.com/" title="Benzinga Premium Product Store, Marketfy.com" class="v3-main-menu-store"><span>Marketfy</span></a></li>
<li class="leaf last menu-mlid-1209092 benzingapro"><a href="https://pro.benzinga.com" title="Benzinga Pro Premium, Realtime Newsfeed" class="v3-main-menu-store"><span>Benzinga Pro</span></a></li>
</ul></div>
  </div>

  
  </div>
            <br style="clear: both;" />
    </div>
  </div>
      <div id="bz3-header-submenu-wrapper">
      <div id="bz3-header-submenu">
        <div class="panel-pane pane-block pane-menu-block-4" >
  
  
  
  <div class="pane-content">
    <div class="menu-block-4 menu-name-menu-v3-main parent-mlid-0 menu-level-2">
  <ul class="menu"><li class="leaf first menu-mlid-878830 active-trail analystcolor"><a href="/analyst-ratings/analyst-color" title="" class="active-trail"><span>Analyst Color</span></a></li>
<li class="leaf menu-mlid-878833 downgrades"><a href="/analyst-ratings/downgrades" title=""><span>Downgrades</span></a></li>
<li class="leaf menu-mlid-878834 upgrades"><a href="/analyst-ratings/upgrades" title=""><span>Upgrades</span></a></li>
<li class="leaf menu-mlid-878831 initiations"><a href="/analyst-ratings/initiation" title=""><span>Initiations</span></a></li>
<li class="leaf last menu-mlid-878828 pricetarget"><a href="/analyst-ratings/price-target" title=""><span>Price Target</span></a></li>
</ul></div>
  </div>

  
  </div>
      </div>
    </div>
        <div id="bz3-header-messages-wrapper">
          </div>
  </div>
<div class="panel-region-separator"></div><div id="bz3-tickerheader-wrapper">
  <div id="bz3-tickerheader">
          <div class="market-overview">
        <div class="panel-pane pane-block pane-bz-custom-bz-custom-market-overview" >
  
      <h2 class="pane-title">Market Overview</h2>
  
  
  <div class="pane-content">
    
  <div id="market-overview-block">
  </div>
    </div>

  
  </div>
      </div>
            <div class="block-head-items">
      <div class="panel-pane pane-bz2-site-search-new" >
  
  
  
  <div class="pane-content">
    <div class="block-ticker-search"><form action="/search/fast"  accept-charset="UTF-8" method="get" id="bz-custom-search-form">
<div><input type="hidden" name="cx" id="edit-cx" value="005794925877256802002:ckazbf3vrxs"  />
<input type="hidden" name="cof" id="edit-cof" value="FORID:11"  />
<div class="form-item" id="edit-query-wrapper">
 <input type="text" maxlength="128" name="query" id="edit-query" size="20" value="" placeholder="Tickers, Articles &amp; Keywords" class="form-text" />
</div>
<div id="custom-search-results"><div class="seperator"><h2>Tickers</h2></div><div class="tickers"></div><div class="seperator"><h2>Articles</h2></div><div class="stories"></div><div class="seperator"><h2>Keywords</h2></div><div class="keywords"><div class="item"><div class="title">Search by keyword...</div><span class="link">googlecse</span></div></div></div><button type="submit" style="font-family:iconic">&#xe810;</button><input type="hidden" name="form_build_id" id="form-WHLMhc4bi7kj-esmutBfpcEahictAE-8VR8s7KWB9Xs" value="form-WHLMhc4bi7kj-esmutBfpcEahictAE-8VR8s7KWB9Xs"  />
<input type="hidden" name="form_id" id="edit-bz-custom-search-form" value="bz_custom_search_form"  />

</div></form>
</div>  </div>

  
  </div>
    </div>
        <div class="enddiv"></div>
  </div> <!-- bz3-tickerheader -->
</div> <!-- bz3-tickerheader-wrapper -->
<div id="benzinga-main-wrapper">
  <div id="benzinga-main" class="benzinga-content-area ">
        <div class="benzinga-content">
      <div class="panel-pane pane-page-content" >
  
  
  
  <div class="pane-content">
    


<div class="article-content">
  <h1 id="title">Despite Drug Trial Miss, Here's Why Biogen Should Trade Higher</h1>
  <div id="node-8791297" class="node full">
          <div class='tabs'></div>
              <div class="article-submitted">

                  <a href="/users/manikandan-raman"><div class="article-picture" style="background-image:url('https://cdn4.benzinga.com/files/imagecache/article_author_thumb/profile_pictures/97707_profPic.jpeg');"></div><a/>
        
        <div class="article-submitted-content">
          <div class="article-author-wrap" data-ng-controller="articleDetail">
  <span class="author">
    <a href="/users/manikandan-raman" class="author-name">Manikandan Raman</a> , Benzinga Staff Writer  </span>

  
  <span class="separator">&nbsp;</span>
  <button
     title="Subscribe to Manikandan Raman"
     class="follow-author"
     data-ng-class="{following: following}"
     data-ng-click="follow('Manikandan Raman')"
     data-ng-init="authorName = 'Manikandan Raman'"
     data-ng-cloak>
      {{following ? "Following" : "Follow"}}
     </button>
</div>
          <div class="article-date-wrap">
            <span class="date">
              December 09, 2016 1:18pm            </span>
            <span class="separator">&nbsp;</span>
            <a class="bz-comments" data-bz-coments="">Comments</a>
          </div>
        </div>
      </div>

      <div class="article-buttons-container">
        <div class="article-buttons article-buttons-top article-share-buttons">
          <div class="article-share-buttons-title">Share:</div>
          <div id="bz-sharebar1" class="bz-sharebar"></div>        </div>
      </div>

            <div class="content clear-block">
      <div class="article-content-body">

        <div id="bz-campaign-text-top" class="bz-campaign-text-top"></div>
                <div class="node-left-corner">
          <div>
            <a rel="lightbox" class="colorbox" alt=" " title=" " href="https://cdn3.benzinga.com/files/imagecache/1024x768xUP/images/story/2012/hands-981400_1920_1.jpg"><img src="https://cdn3.benzinga.com/files/imagecache/story_image_685x375C/images/story/2012/hands-981400_1920_1.jpg" alt="Despite Drug Trial Miss, Here&#039;s Why Biogen Should Trade Higher" title="Biogen Stock: Despite Drug Trial Miss, BIIB Should Trade Higher" width="685" height="375" class="imagecache imagecache-story_image_685x375C"/></a>                                  </div>
        </div>
        
        
                  <div class="article-related-left">
  <div class="title">Related <a href="/stock/BIIB">BIIB</a></div>
      <div class="article">
    <a href="/general/biotech/17/07/9784256/exclusive-verastem-ceo-talks-duvelisib-pipeline-data-and-further-upsid">Exclusive: Verastem CEO Talks Duvelisib, Pipeline Data, And Further Upside For The Stock</a>        </div>
      <div class="article">
    <a href="/analyst-ratings/upgrades/17/07/9762937/benzingas-top-upgrades-downgrades-for-july-11-2017">Benzinga&#039;s Top Upgrades, Downgrades For July 11, 2017</a>        </div>
      <div class="article">
    <a href="http://www.investors.com/research/ibd-industry-themes/biotechs-on-a-hot-streak-and-could-be-cooking-with-gas/?src=A00237A&amp;ven=BenzingaCP&amp;src=AURLAAM">Biotechs On A Hot Streak, And Could Be &#039;Cooking With Gas&#039;</a>          <span class="partner">(Investor's Business Daily)</span> 
        </div>
  </div>
        
        
        <p>BMO Capital Markets said <strong>Biogen Inc</strong> (NASDAQ: <a class="ticker" href="/stock/biib#NASDAQ">BIIB</a>) shares should trade higher, despite a recent drug trial miss, on CTAD data (Clinical Trials on <a href="http://www.benzinga.com/analyst-ratings/analyst-color/16/11/8738941/reasons-to-be-optimistic-on-biogens-alzheimers-treatment">Alzheimer&#39;s</a> Disease).</p>
<p>The <a href="https://www.benzinga.com/general/biotech/16/12/8788078/biogen-spikes-on-leaked-data">CTAD </a>data show:</p>
<li>&ldquo;<a href="http://www.benzinga.com/general/biotech/16/11/8733840/eli-lillys-solanezumab-failure-is-bad-news-for-biogen">Solanezumab </a>caused small yet consistent improvements on secondary endpoints, including CDR-SB (aducanumab&#39;s P3 endpoint).&rdquo;</li>
<p><lI>&ldquo;Aducanumab titration yielded efficacy similar to 6&ndash;10mg/kg doses.&rdquo;</li>
</p><p>However, the brokerage maintains its Market Perform rating on Biogen shares, with a price target of $331.</p>
<h3>To Go More Bullish</h3>
<p>&ldquo;In order to get more constructive on BIIB, on Friday, we want to see data regarding: (1) ARIA-E severity in titration cohort; (2) 24- month efficacy magnitude; and (3) cognitive benefit from placebo patients switching to aducanumab in LTE,&rdquo; analyst Ian&nbsp;Somaiya wrote in a note.</p>
<p>Earlier in Friday's morning session, hares of Biogen rose 5.13 percent to $304.39; however, at last check, shares were up just 0.94 percent at $292.25.</p>
<div class="article-extra">
  <h3>Latest Ratings for BIIB</h3>
  <table style="width: 100%" class="stock-ratings-calendar stock-calendar-table-data sticky-enabled">
 <thead><tr><th>Date</th><th>Firm</th><th>Action</th><th>From</th><th>To</th> </tr></thead>
<tbody>
 <tr class="odd"><td>Jul 2017</td><td>Jefferies</td><td class="">Assumes</td><td></td><td>Hold</td> </tr>
 <tr class="even"><td>Jul 2017</td><td>Morgan Stanley</td><td class="">Maintains</td><td></td><td>Equal-Weight</td> </tr>
 <tr class="odd"><td>Jun 2017</td><td>Deutsche Bank</td><td class="">Initiates Coverage On</td><td></td><td>Buy</td> </tr>
</tbody>
</table>
  <p>
    <a href="/stock/BIIB/ratings" class="article-extra-ratings-link-single">View More Analyst Ratings for BIIB</a>
    <br />
    <a href="/calendar/ratings" class="article-extra-ratings-link-all">View the Latest Analyst Ratings</a>
  </p>
</div>
        
        
        
        <div id="bz-campaign-text-bottom" class="bz-campaign-text-bottom"></div>
                  <p class="article-taxonomy-bottom"><strong>Posted-In:</strong> <a href="/analyst-ratings/analyst-color">Analyst Color</a> <a href="/general/biotech">Biotech</a> <a href="/news">News</a> <a href="/general/health-care">Health Care</a> <a href="/analyst-ratings/price-target">Price Target</a> <a href="/analyst-ratings/reiteration">Reiteration</a> <a href="/analyst-ratings">Analyst Ratings</a> <a href="/movers">Movers</a> <a href="/best-of-benzinga">Best of Benzinga</a></p>
        
                  <p class="copyright"><i>&copy; 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.</i></p>              </div>

      
      
      <div style="clear: both;font-size:1px;line-height:1px;" class="article-content-end">&nbsp;</div>
    </div>

    
    
    <div class="article-more-stories">
            <div class="article-more-stories related-articles">
        <h4>Related Articles (BIIB)</h4>
        <div class="view view-bz3-articlepage-more-stories view-id-bz3_articlepage_more_stories view-display-id-block_2 view-dom-id-1">
    
  
  
      <div class="view-content">
        <div class="views-row views-row-1 views-row-odd views-row-first">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/general/biotech/17/07/9784256/exclusive-verastem-ceo-talks-duvelisib-pipeline-data-and-further-upsid">Exclusive: Verastem CEO Talks Duvelisib, Pipeline Data, And Further Upside For The Stock</a></span>
  </div>
  </div>
  <div class="views-row views-row-2 views-row-even">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/analyst-ratings/upgrades/17/07/9762937/benzingas-top-upgrades-downgrades-for-july-11-2017">Benzinga&#039;s Top Upgrades, Downgrades For July 11, 2017</a></span>
  </div>
  </div>
  <div class="views-row views-row-3 views-row-odd">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/general/biotech/17/07/9757779/the-royalty-amassing-strategy-of-royalty-pharma">The Royalty-Amassing Strategy Of Royalty Pharma</a></span>
  </div>
  </div>
  <div class="views-row views-row-4 views-row-even">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/analyst-ratings/analyst-color/17/07/9757715/cowen-upgrades-bioverativ-shares-to-outperform-as-tnt009">Cowen Upgrades Bioverativ Shares To Outperform As TNT009 Heats Up</a></span>
  </div>
  </div>
  <div class="views-row views-row-5 views-row-odd">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/analyst-ratings/analyst-color/17/06/9646667/deutsche-banks-take-on-big-pharma-3-buys-and-a-hold">Deutsche Bank&#039;s Take On Big Pharma: 3 Buys And A Hold</a></span>
  </div>
  </div>
  <div class="views-row views-row-6 views-row-even views-row-last">
      
  <div class="views-field-title">
                <span class="field-content"><a href="/news/17/06/9640369/wall-streets-m-a-chatter-from-june-21-staples-sycamore-partners-diageo-casamigos-">Wall Street&#039;s M&amp;A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma</a></span>
  </div>
  </div>
    </div>
  
  
  
  
  
  
</div>       </div>
          </div>

    <a id="show-comments-button">View Comments and Join the Discussion!</a>
    <div id="disqus_thread"></div><noscript><div class="disqus-noscript"><a href="http://bzdisqus.disqus.com/?url=http%3A%2F%2Fwww.benzinga.com%2Fanalyst-ratings%2Fanalyst-color%2F16%2F12%2F8791297%2Fdespite-drug-trial-miss-heres-why-biogen-should-trade-hi">View the discussion thread.</a></div></noscript>
                <script>document.write('<iframe width="685" height="300" marginheight=0 marginwidth=0 frameborder=0 vspace=0 hspace=0 scrolling=NO  src="//www.dianomi.com/smartads.epl?id=2224&url='+escape(document.location.href)+'"></iframe>')</script>
  </div>
</div>
  </div>

  
  </div>
    </div>
    
        <div class="benzinga-blocks">
      <div class="panel-pane pane-block pane-bzads-bzadwrapper-300x250-top-right-article" >
  
  
  
  <div class="pane-content">
    <div id='ic_300x250_1'><script src='//ads.investingchannel.com/adtags/benzinga/equities/300x250.js?ad_element_id=ic_300x250_1&zhpos=300_1' type='text/javascript' charset='utf-8' async></script></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-block pane-bz-custom-bz-custom-benzinga-newsletter-signup" >
  
  
  
  <div class="pane-content">
    <div id="benzinga-newsletter-signup">
  <div class="form-container">
    <div class="header">
      <div class="logo">
        <img src="https://cdn1.benzinga.com/sites/all/themes/bz2/images/bz-logo-flat-250x88.png" alt="bz-logo">
      </div>
      <div class="header-text">
        Newsletter & Alerts
      </div>
    </div>
    <div class="input-container">
      <form
        id='form'
        action=''
        method="POST"
      >
        <div class="input-name-row">
          <input
            id="input-name"
            class="input-name"
            name="name"
            placeholder="NAME"
            type="text"
          />
        </div>
        <div class="input-email-row">
          <input
            id="input-email"
            class="input-email"
            name="email"
            placeholder="EMAIL ADDRESS"
            type="text"
          />
        </div>
        <div class="slogan">
          Become a Wall-Street Wizard.
        </div>
        <div class="form-selection">
          <div class="market-in-five">
            <input type="checkbox" name="form" value="marketin5" id="market-checkbox" checked>
            <div class="description">
              <div class="form-title" id="market-checkbox-title">Market in 5 Minutes</div>
              <div class="form-summary">Everything you need to know about the market - quick & easy.</div>
            </div>
          </div>
          <div class="daily-analyst">
            <input type="checkbox" name="form" value="dailyanalyst" id="analyst-checkbox" checked>
            <div class="description">
              <div class="form-title description" id="analyst-checkbox-title">Daily Analyst Rating</div>
              <div class="form-summary">A summary of each day’s top rating changes from sell-side  analysts on the street.</div>
            </div>
          </div>
          <div class="fintech-focus">
            <input type="checkbox" name="form" value="fintechfocus" id="fintech-checkbox" checked>
            <div class="description">
              <div class="form-title description" id="fintech-checkbox-title">FinTech Focus</div>
              <div class="form-summary">Yesterday’s biggest gainers and losers. As well as 10 stocks to keep an eye on for Today</div>
            </div>
          </div>
        </div>
        <input
          class="input-submit"
          type="button"
          value="Sign Me Up!"
        />
        <div class="footer">
          <div class="terms">
            <a href="https://www.benzinga.com/terms-and-conditions" target="_blank">TERMS & CONDITIONS</a>
          </div>
        </div>
      </form>
      <div class="thankyou-container">
        <div class="thankyou-header">
          <div class="thankyou-header-main">Thank You</div>
          <div class="thankyou-header-sub">for registering for Benzinga’s newsletters and alerts.</div>
        </div>
        <div class="thankyou-body">
          <div class="hours-of-service">
            • The Daily Analysts Ratings email will be received daily between 7am and 10am.
          </div>
          <div class="hours-of-service">
            • The Market in 5 Minutes email will be received daily between 7am and 8am.
          </div>
          <div class="hours-of-service">
            • The Fintech Focus email will be received every Friday between 2pm and 5pm.
          </div>
        </div>
        <div class="thankyou-footer">
          If you have any questions as it relates to either of the three newsletters, please feel free to contact us at  1-877-440-ZING.
        </div>
      </div>
    </div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-block pane-bz-watchlist-bz-watchlist-cta" >
  
  
  
  <div class="pane-content">
    <a class="bz-watchlist-cta" href="/profile">
  Sign up for email alerts on <strong>BIIB</strong>
</a>
  </div>

  
  </div>
<div class="panel-region-separator"></div><div id="top-stories-block" class="block">
    <div class="block-tabs">
      <ul>
        <li><a href="javascript:void(0)" class="orange">Trending</a></li>
        <li><a href="javascript:void(0)" class="blue">Recent</a></li>
      </ul>
    </div>
    <div class="block-shadow block-border">
      <div class="block-themes-content">
        <div class="content">
          <div class="item-list">
            <table>
          <tr>
            <td class='most-count'><a href='/analyst-ratings/analyst-color/17/07/9784480/different-market-same-story-subprime-auto-loan-defaults-'>1</a></td>
            <td><a href='/analyst-ratings/analyst-color/17/07/9784480/different-market-same-story-subprime-auto-loan-defaults-'><strong>SC, COF</strong>: Different Market, Same Story: Subprime Auto Loan Defaults On The Rise</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/analyst-ratings/analyst-color/17/07/9790994/the-restaurant-sector-q2-earnings-cheat-sheet'>2</a></td>
            <td><a href='/analyst-ratings/analyst-color/17/07/9790994/the-restaurant-sector-q2-earnings-cheat-sheet'><strong>TAST, DIN</strong>: The Restaurant Sector Q2 Earnings Cheat Sheet</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/media/cnbc/17/07/9801282/cramers-plea-to-new-investors-dont-just-listen-to-me-do-your-homework'>3</a></td>
            <td><a href='/media/cnbc/17/07/9801282/cramers-plea-to-new-investors-dont-just-listen-to-me-do-your-homework'><strong>NVDA</strong>: Cramer&#039;s Plea To New Investors: Don&#039;t Just Listen...</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/news/17/07/9808884/hollywood-seeks-salvation-at-san-diego-comic-con-in-midst-of-summers-box-office-s'>4</a></td>
            <td><a href='/news/17/07/9808884/hollywood-seeks-salvation-at-san-diego-comic-con-in-midst-of-summers-box-office-s'><strong>SNE, TWX</strong>: Hollywood Seeks Salvation At San Diego Comic-Con In...</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/news/17/07/9807047/tech-sector-finally-recovers-from-the-dot-com-bubble-of-2000'>5</a></td>
            <td><a href='/news/17/07/9807047/tech-sector-finally-recovers-from-the-dot-com-bubble-of-2000'><strong>INTC, ORCL</strong>: Tech Sector Finally Recovers From The Dot-...</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/general/psychology/17/07/9795403/amazon-is-the-google-of-shopping-a-third-of-americans-first-look-on'>6</a></td>
            <td><a href='/general/psychology/17/07/9795403/amazon-is-the-google-of-shopping-a-third-of-americans-first-look-on'><strong>AMZN, GOOGL</strong>: Amazon Is The Google Of Shoppin...</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/news/earnings/17/07/9804019/dow-30-earnings-score-card-from-the-past-week-ibm-visa-goldman-and-more'>7</a></td>
            <td><a href='/news/earnings/17/07/9804019/dow-30-earnings-score-card-from-the-past-week-ibm-visa-goldman-and-more'><strong>TRV, JNJ</strong>: Dow 30 Earnings Score C...</a></td>
          </tr>
        </table>          </div>
        </div>
        <div class="content tab-content-hide">
          <div class="item-list">
            <table>
          <tr>
            <td class='most-count'><a href='/news/17/07/9809473/economic-data-scheduled-for-monday'>1</a></td>
            <td><a href='/news/17/07/9809473/economic-data-scheduled-for-monday'>Economic Data Scheduled For Monday</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/news/earnings/17/07/9809470/earnings-scheduled-for-july-24-2017'>2</a></td>
            <td><a href='/news/earnings/17/07/9809470/earnings-scheduled-for-july-24-2017'><strong>RYAAY, RPM</strong>: Earnings Scheduled For July 24, 2017</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/markets/options/17/07/9809466/watch-these-5-huge-put-purchases-in-monday-trade'>3</a></td>
            <td><a href='/markets/options/17/07/9809466/watch-these-5-huge-put-purchases-in-monday-trade'><strong>APC, FB</strong>: Watch These 5 Huge Put Purchases In Monday Trade</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/markets/options/17/07/9809462/watch-these-5-huge-call-purchases-in-monday-trade'>4</a></td>
            <td><a href='/markets/options/17/07/9809462/watch-these-5-huge-call-purchases-in-monday-trade'><strong>BJRI, MDLZ</strong>: Watch These 5 Huge Call Purchases In Monday Trade</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/general/education/17/07/9788641/investors-bailing-on-hedge-funds'>5</a></td>
            <td><a href='/general/education/17/07/9788641/investors-bailing-on-hedge-funds'><strong>AMZN, TSLA</strong>: Investors Bailing On Hedge Funds</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/personal-finance/financial-advisors/17/07/9806801/picking-marijuana-related-investments-phyto-partne'>6</a></td>
            <td><a href='/personal-finance/financial-advisors/17/07/9806801/picking-marijuana-related-investments-phyto-partne'><strong>THCBF, SMG</strong>: Picking Marijuana-Related Investm...</a></td>
          </tr>
        
          <tr>
            <td class='most-count'><a href='/news/17/07/9784257/wide-spanning-market-implications-when-fed-changes-its-tone'>7</a></td>
            <td><a href='/news/17/07/9784257/wide-spanning-market-implications-when-fed-changes-its-tone'><strong>SPX, FED</strong>: Wide-Spanning Market Impl...</a></td>
          </tr>
        </table>          </div>
        </div>
      </div>
    </div>
</div>
<div class="panel-region-separator"></div><div class="panel-pane pane-block pane-bzads-bzadwrapper-300x250-middle-right" >
  
  
  
  <div class="pane-content">
    <div id='ic_300x250_2'><script src='//ads.investingchannel.com/adtags/benzinga/equities/300x250.js?ad_element_id=ic_300x250_2&zhpos=300_2' type='text/javascript' charset='utf-8' async></script></div>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-block pane-bz-custom-bz-custom-calendar-link" >
  
  
  
  <div class="pane-content">
    <a href="/calendar/earnings" class="calendar_block_link">View upcoming Earnings, Ratings, Dividend and Economic Calendars.</a>  </div>

  
  </div>
<div class="panel-region-separator"></div><div class="panel-pane pane-bz2-sidebar-sponsored-random" >
  
  
  
  <div class="pane-content">
    <div class=""><div id="bzadwrapper-300x250-bottom-right"><div id='ic_300x250_3'><script src='//ads.investingchannel.com/adtags/benzinga/equities/300x250.js?ad_element_id=ic_300x250_3&zhpos=300_3' type='text/javascript' charset='utf-8' async></script></div></div></div>  </div>

  
  </div>
    </div>
        <div class="enddiv"></div>
  </div>
</div>

  <div id="benzinga-footer">
  <div id="benzinga-footer-inner">
    <div class="benzinga-footer-tag">
      <div class="benzinga-block">
        <div class="benzinga-footer-logo">
        </div>
        <div class="benzinga-footer-text">
          Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
        </div>
      </div>
    </div>
    <div class="benzinga-footer-links benzinga-footer-links-categories">
      <div class="block-columns">
                  <div class="block-column block-column-catecories">
  <div class="item-list"><h2>Popular Channels</h2><ul><li class="first"><a href="/analyst-ratings" title=""><span>Analyst Ratings</span></a></li>
<li ><a href="/be-your-own-boss" title=""><span>Be Your Own Boss</span></a></li>
<li ><a href="/etfs" title=""><span>ETFs</span></a></li>
<li ><a href="/economics" title=""><span>Economics</span></a></li>
<li ><a href="/markets/forex" title=""><span>Forex</span></a></li>
<li ><a href="/hot" title=""><span>Hot</span></a></li>
<li ><a href="/news" title=""><span>News</span></a></li>
<li ><a href="/markets/options" title=""><span>Options</span></a></li>
<li ><a href="/pressreleases" title=""><span>Press Releases</span></a></li>
<li ><a href="/startups" title=""><span>Start-ups</span></a></li>
<li class="last"><a href="/tech" title=""><span>Tech</span></a></li>
</ul></div><div class="panel-region-separator"></div><div class="item-list"><h2>Tools &amp; Features</h2><ul><li class="first"><a href="http://benzinga.postaffiliatepro.com/affiliates" title="Benzinga&#039;s Affiliate Program"><span>Affiliate Program</span></a></li>
<li ><a href="http://premarket.benzinga.com" title="PreMarket Prep"><span>PreMarket Prep</span></a></li>
<li ><a href="/feeds/list" title=""><span>Feeds</span></a></li>
<li ><a href="/partners/widgets" title=""><span>News Widget</span></a></li>
<li ><a href="/widgets/live-updates" title=""><span>Real Time Feed</span></a></li>
<li ><a href="/sitemap" title=""><span>Sitemap</span></a></li>
<li class="last"><a href="/contact" title=""><span>Submit News Tips</span></a></li>
</ul></div><div class="panel-region-separator"></div><div class="item-list"><h2>About Benzinga</h2><ul><li class="first"><a href="/about" title=""><span>About Us</span></a></li>
<li ><a href="http://cloud.benzinga.com" title="Benzinga Cloud - Licensing and APIs"><span>Licensing and APIs</span></a></li>
<li ><a href="http://www.benzinga.com/apps" title=""><span>Apps (iOS and Android)</span></a></li>
<li ><a href="http://benzingafintechawards.com/" title=""><span>Fintech Awards</span></a></li>
<li ><a href="/blog" title=""><span>Blog</span></a></li>
<li ><a href="/syndication" title=""><span>Syndication</span></a></li>
<li ><a href="/inthenews" title="Media"><span>In the News</span></a></li>
<li ><a href="http://jobs.benzinga.com" title=""><span>Careers</span></a></li>
<li ><a href="http://www.benzingastatus.com/" title="Benzinga Services, APIs, Uptime, Downtime, Status"><span>Service Status</span></a></li>
<li ><a href="/contact" title=""><span>Contact Us</span></a></li>
<li ><a href="/disclaimer" title="Disclaimer"><span>Disclaimer</span></a></li>
<li ><a href="/page/privacy" title=""><span>Privacy Policy</span></a></li>
<li class="last"><a href="/terms-and-conditions" title="Terms and Conditions"><span>Terms and Conditions</span></a></li>
</ul></div></div>
<div class="panel-region-separator"></div><div class="benzinga-footer-partners">
    <a name="partners" class="partners-anchor"><h2>Benzinga Partners</h2></a>
    <div>              </div>
    </div>
  </div>
</div> <!-- benzinga footer -->
<div class="site-footer-links">
  <div class="benzinga-block">
          <div class="block-column block-column-catecories"><span class="left">1 (877) 440-9464 (ZING)</span>
    <span class="right">&copy; Copyright Benzinga</span></div><div class="panel-region-separator"></div><div class="panel-pane pane-block pane-bzcustom-bzcustom-social-links" >
  
  
  
  <div class="pane-content">
    
    <div class="bz-social-links">
      <a href="http://www.facebook.com/pages/Benzingacom/159483118580?v=app_7146470109"><i class="fa fa-facebook-square"></i></a>
      <a href="http://twitter.com/benzinga"><i class="fa fa-twitter-square"></i></a>
      <a href="http://www.linkedin.com/company/benzinga"><i class="fa fa-linkedin-square"></i></a>
      <a href="https://plus.google.com/108838891574408087738/posts"><i class="fa fa-google-plus-square"></i></a>
      <a href="http://feeds.benzinga.com/benzinga"><i class="fa fa-rss-square"></i></a>
    </div>
    </div>

  
  </div>
      </div>
</div>

  <!-- To place the slidedown menu on all pages. -->
  <div class="bz-subnav-container">
    <nav class="bz-subnav-box" role="navigation">
      <div class="subnav-logo-wrapper">
        <a href="http://www.benzinga.com/" class="bz-subnav-box__logo">
          <span class="visuallyhidden">Benzinga - Feed Your Mind</span>
        </a>
        <div class="trypro-wrapper">
          <a href="https://pro.benzinga.com?utm_source=trypro&utm_campaign=trypro" target="_blank">try pro</a>
        </div>
      </div>
     
      <ul class="bz-subnav-box__links">
        <li><a href="/news"><span>News</span></a></li>
        <li><a href="/markets"><span>Markets</span></a></li>
        <li><a href="/analyst-ratings"><span>Ratings</span></a></li>
        <li><a href="/trading-ideas"><span>Ideas</span></a></li>
        <li><a href="/tech"><span>Tech</span></a></li>
        <li><a href="/news/small-cap"><span>Small-Cap</span></a></li>
        <li><a href="/personal-finance"><span>Personal Finance</span></a></li>
        <li><a href="http://marketfy.com/"><span>Premium Products</span></a></li>
      </ul>
    </nav>
  </div>

  
  <div id="closure"><script src="https://www.benzinga.com/sites/all/libraries/benzinga-ticker-widget/js/highcharts.js"></script><a href="https://www.benzinga.com/news/16/12/8791769/more-metric-mishaps-how-has-this-impacted-facebook-shares-before" class="article-prev-next forward with-image">
  <div class="article-prev-next-arrow"></div>
  <div class="article-prev-next-title"><h4>More Metric Mishaps; How Has This Impacted Facebook Shares Before?</h4></div>
  <div class="article-prev-next-image"><img src="https://cdn4.benzinga.com/files/imagecache/250x250C/images/story/2012/facebook-1602262_1920_1_1.jpg" alt="" /></div></a>
<a href="https://www.benzinga.com/news/16/12/8792030/invensense-in-talks-to-be-acquired" class="article-prev-next back with-image">
  <div class="article-prev-next-arrow"></div>
  <div class="article-prev-next-title"><h4>InvenSense In Talks To Be Acquired</h4></div>
  <div class="article-prev-next-image"><img src="https://cdn4.benzinga.com/files/imagecache/250x250C/images/story/2012/invi.jpg" alt="" /></div></a>
<script type="text/javascript" src="https://cdn3.benzinga.com/files/advagg_js/js_3f0651e8b44917098f48116e541c211a_80.js"></script>
<script type="text/javascript" src="https://cdn1.benzinga.com/files/advagg_js/js_75a02c93daf3cce0dfece9e23ddb13ac_15.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings, {"googleCSE":{"language":"en"}});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _sf_async_config=_sf_async_config||{};_sf_async_config.sections='Analyst Color,Biotech,News,Health Care,Price Target,Reiteration,Analyst Ratings,Movers,General';_sf_async_config.authors='Manikandan Raman';
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
analytics.identify('0',{name:'Anonymous'});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var analyticsProperties={};if(typeof Drupal.settings.bz_js!=='undefined'&&typeof Drupal.settings.bz_js.analytics_properties!=='undefined'){analyticsProperties=Drupal.settings.bz_js.analytics_properties;if(typeof Drupal.settings.bz_js.nodeCreated!=='undefined'){var nodeCreated=Drupal.settings.bz_js.nodeCreated,today=Date.now()/1e3,numberOfDays=(today-nodeCreated)/(60*60*24);if(numberOfDays>2e3){ageOfArticle=1e4}else{var rangeArray=[0,1,2,3,5,7,10,15,20,30,60,90,180,365,730,1e3,2e3];for(var i in rangeArray)if(numberOfDays<=rangeArray[i]&&numberOfDays>rangeArray[i-1]){ageOfArticle=rangeArray[i];break}};analyticsProperties.ageOfArticle=ageOfArticle}};analytics.page(analyticsProperties);
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
analytics.trackLink($("body.page-node .article-content a.article-extra-ratings-link-single"),"Click",{category:"Article Extra",label:"Article Extra: Ratings Ticker Link"});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
analytics.trackLink($("body.page-node .article-content a.article-extra-ratings-link-all"),"Click",{category:"Article Extra",label:"Article Extra: Ratings Calendar Link"});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){$('.article-content-body').bztooltipwidget({inlineQuoteDisplay:true,debug:false,afterReplace:function(){$('iframe.twitter-tweet').remove();$('blockquote.twitter-tweet').removeAttr('data-twttr-rendered');var s=document.createElement('script');s.type='text/javascript';s.src='//platform.twitter.com/widgets.js';$('head').append(s)}})});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){if($('#bz-sharebar1').sharing_widget)$('#bz-sharebar1').sharing_widget({nid:8791297,url:'',url_short:'',title_twitter:"Despite Drug Trial Miss, Here's Why Biogen Should Trade Higher https:\/\/benzinga.com\/z\/8791297 $BIIB ",style:'share-btn--responsive',tooltip:true,tooltip_prop:'hint--bottom',networks_show:' facebook twitter linkedin googleplus print email',endpoint_base_url:"https:\/\/www.benzinga.com",share_callback:analyticsTrackCB})});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){googletag.cmd.push(function(){googletag.display('div-gpt-ad-1346271905130-0')})});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
analytics.trackLink($("a.bz-watchlist-cta"),"Click",{category:"Watchlist CTA",label:"Watchlist CTA: Text Block"});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){googletag.cmd.push(function(){googletag.display('div-gpt-ad-1346271905130-0')})});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
analytics.trackLink($("a.calendar_block_link"),"Click",{category:"Calendar Block Link",label:"Calendar Block Link"});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){googletag.cmd.push(function(){googletag.display('div-gpt-ad-1346271905130-0')})});
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
$(function(){googletag.cmd.push(function(){googletag.display('div-gpt-ad-1353985507499-0')})});
//--><!]]>
</script>
</div>
</body>
</html>
